Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Ivermectin B1a(Synonyms: Ivermectin, 22,23-Dihydroavermectin B1a, Avermectin B1a, MK-933, Stromectol, Mectizan), 5mg, CAS: 71827-03-7.
SDP

Catalog No. 5000061390
Encompass_Preferred

Ivermectin B1a (CAS 71827-03-7) is the primary constituent ( 80%) of the antiparasitic macrocyclic lactone ivermectin Its pharmacological effects originate from selective interaction with glutamate-gated chloride ion channels prevalent in neurons and pharyngeal muscles of nematodes This binding induces durable chloride influx causing sustained hyperpolarization or depolarization resulting in neuromuscular paralysis Ivermectin displays potent antiparasitic efficacy (EC 104 nM) and is clinically significant in treating human onchocerciasis reducing symptoms associated with the infection

Catalog No. 50-000-61390 Supplier Apexbio Technology LLC Supplier No. C39055
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ivermectin B1a (CAS 71827-03-7) is the primary constituent ( 80%) of the antiparasitic macrocyclic lactone ivermectin Its pharmacological effects originate from selective interaction with glutamate-gated chloride ion channels prevalent in neurons and pharyngeal muscles of nematodes This binding induces durable chloride influx causing sustained hyperpolarization or depolarization resulting in neuromuscular paralysis Ivermectin displays potent antiparasitic efficacy (EC 104 nM) and is clinically significant in treating human onchocerciasis reducing symptoms associated with the infection

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.